Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Other financing activities (2016 - 2018)

Historic Other financing activities for Soleno Therapeutics (SLNO) over the last 5 years, with Q3 2018 value amounting to $700000.0.

  • Soleno Therapeutics' Other financing activities changed N/A to $700000.0 in Q3 2018 from the same period last year, while for Dec 2018 it was $1.5 million, marking a year-over-year increase of 57777.78%. This contributed to the annual value of $16000.0 for FY2022, which is 8666.67% down from last year.
  • As of Q3 2018, Soleno Therapeutics' Other financing activities stood at $700000.0.
  • Soleno Therapeutics' Other financing activities' 5-year high stood at $1.8 million during Q4 2014, with a 5-year trough of -$71000.0 in Q2 2016.
  • For the 5-year period, Soleno Therapeutics' Other financing activities averaged around $429739.8, with its median value being $312500.0 (2017).
  • Per our database at Business Quant, Soleno Therapeutics' Other financing activities plummeted by 9754.61% in 2015 and then plummeted by 8660.38% in 2016.
  • Soleno Therapeutics' Other financing activities (Quarter) stood at $1.8 million in 2014, then tumbled by 97.55% to $45181.0 in 2015, then tumbled by 257.15% to -$71000.0 in 2016, then surged by 416.9% to $225000.0 in 2017, then skyrocketed by 211.11% to $700000.0 in 2018.
  • Its Other financing activities stands at $700000.0 for Q3 2018, versus $425000.0 for Q2 2018 and $400000.0 for Q1 2018.